Recent articles
Why Neoleukin Therapeutics Stock Is Down Today
The company is experiencing regulatory headwinds.
Why Fulgent Genetics Stock Is Dropping Today
A Wall Street analyst downgraded the genetics testing provider.
Why ViewRay Stock Dropped Today
The company announced the pricing of a public offering of common stock.
Why Intellia Therapeutics Stock Is Soaring Today
Investors are looking forward to what could be a great year for the biotechnology company.
Expecting a $600 Stimulus Check? These 2 Stocks Should Rebound Big
After a relatively poor performance in 2020, these two companies are poised to perform much better in the new year.
Why Calithera Biosciences Stock Is Plunging Today
The company reported negative results from a clinical trial.
Why Osmotica Pharmaceuticals Stock Plunged Today
One of the company's pipeline candidates ran into a regulatory hurdle.
Why Supernus Pharmaceuticals Stock Is Rising Today
The company announced positive results from a clinical trial.
Under 30? 2 Unstoppable Stocks to Bet Your Retirement On
These two surefire bets are excellent options for young investors building a nest egg.
Why Quidel Corporation Stock Is Jumping Today
One of the company's COVID-19 tests received emergency use authorization.
Forget Apple: Here's a Better Dividend Growth Stock
In terms of its payouts to shareholders, drugmaker Amgen has better stats than the tech powerhouse.
Why Greenwich LifeSciences Stock Is Plunging Today
The company announced the pricing of a public offering of common stock.
Why Fortress Biotech Stock Jumped Today
One of the company's subsidiaries announced some good news today.
Why Anavex Life Sciences Stock Jumped Today
The company reported positive results from a phase 2 clinical trial.
Why Eli Lilly Stock Jumped Today
The company released positive results from a pivotal clinical trial.
Why Cantel Medical Stock Is Soaring Today
The company's latest quarterly earnings report managed to impress investors.
Why Ovid Therapeutics Stock Is Imploding Today
The company reported disappointing results from a late-stage clinical trial.
Why Schrodinger Stock Is Rising Today
The company announced a partnership with Bristol Myers Squibb.
Why MeiraGTx Holdings Stock Is Down Today
The company announced the pricing of a public offering of common stock.
Why BrainStorm Cell Therapeutics Stock Imploded Today
The company reported disappointing results from a pivotal clinical trial.